The future of iPS cells in advancing regenerative medicine

Genetics Research

Volumn 98, Issue , 2016, Pages

  Liu, Peng ^a   Li, Ke ^a   Xu, Shaohua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CRISPR CAS SYSTEM; HIGH THROUGHPUT SEQUENCING; HUMAN; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY; REGENERATIVE MEDICINE; TRANSPLANTATION; TRENDS;

ANIMALS; CELL DIFFERENTIATION; CRISPR-CAS SYSTEMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84957818403     PISSN: 00166723     EISSN: 14695073     Source Type: Journal    
DOI: 10.1017/S001667231600001X     Document Type: Article

References (49)

1. Alipio, Z., Liao, W., Roemer, E. J., Waner, M., Fink, L. M., Ward, D. C. & Ma, Y. (2010). Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proceedings of the National Academy of Sciences of the United States of America 107, 13426-13431.
2. Chakraborty, S., Ji, H., Kabadi, A. M., Gersbach, C. A., Christoforou, N. & Leong, K. W. (2014). A CRISPR/ Cas9-based system for reprogramming cell lineage specification. Stem Cell Reports 3, 940-947.
3. Chavez, A., Scheiman, J., Vora, S., Pruitt, B. W., Tuttle, M., P. R. Iyer, E. Lin, S., Kiani, S., Guzman, C. D., Wiegand, D. J., Ter-Ovanesyan, D., Braff, J. L., Davidsohn, N., Housden, B. E., Perrimon, N., Weiss, R., Aach, J., Collins, J. J. & Church, G. M. (2015). Highly efficient Cas9-mediated transcriptional programming. Nature Methods 12, 326-328.
4. Cherry, A. B. & Daley, G. Q. (2013). Reprogrammed cells for disease modeling and regenerative medicine. Annual Review of Medicine 64, 277-290.
5. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A. & Zhang, F. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823.
6. Dimmeler, S., Ding, S., Rando, T. A. & Trounson, A. (2014). Translational strategies and challenges in regenerative medicine. Nature Medicine 20, 814-821.
7. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C. E. & Eggan, K. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
8. Gao, X., Tsang, J. C., Gaba, F., Wu, D., Lu, L. & Liu, P. (2014). Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Research 42, e155.
9. Garber, K. (2015). RIKEN suspends first clinical trial involving induced pluripotent stem cells. Nature Biotechnology 33, 890-891.
10. Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., Qi, L. S., Kampmann, M. & Weissman, J. S. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647-661.
11. Hadjur, S., Williams, L. M., Ryan, N. K., Cobb, B. S., Sexton, T., Fraser, P., Fisher, A. G. & Merkenschlager, M. (2009). Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 460, 410-413.
12. Jha, B. S. & Bharti, K. (2015). Regenerating retinal pigment epithelial cells to cure blindness: a road towards personalized artificial tissue. Current Stem Cell Reports 1, 79-91.
13. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A. & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821.
14. Kagey, M. H., Newman, J. J., Bilodeau, S., Zhan, Y., Orlando, D. A., van Berkum, N. L., Ebmeier, C. C., Goossens, J., Rahl, P. B., Levine, S. S., Taatjes, D. J., Dekker, J. & Young, R. A. (2010). Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430-435.
15. Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., Kiryu, J. & Takahashi, M. (2014). Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports 2, 205-218.
16. Kazuki, Y., Hiratsuka, M., Takiguchi, M., Osaki, M., Kajitani, N., Hoshiya, H., Hiramatsu, K., Yoshino, T., Kazuki, K., Ishihara, C., Takehara, S., Higaki, K., Nakagawa, M., Takahashi, K., Yamanaka, S. & Oshimura, M. (2010). Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Molecular Therapy 18, 386-393.
17. Kearns, N. A., Genga, R. M., Enuameh, M. S., Garber, M., Wolfe, S. A. & Maehr, R. (2014). Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development 141, 219-223.
18. Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., Nureki, O. & Zhang, F. (2015). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583-588.
19. Lassar, A. B., Paterson, B. M. & Weintraub, H. (1986). Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47, 649-656.
20. Li, W., Li, K., Wei, W. & Ding, S. (2013). Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 13, 270-283.
21. Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H. & Joung, J. K. (2013). CRISPR RNA-guided activation of endogenous human genes. Nature Methods 10, 977-979.
22. Misteli, T. (2007). Beyond the sequence: cellular organization of genome function. Cell 128, 787-800.
23. Narsinh, K. H., Sun, N., Sanchez-Freire, V., Lee, A. S., Almeida, P., Hu, S., Jan, T., Wilson, K. D., Leong, D., Rosenberg, J., Yao, M., Robbins, R. C. & Wu, J. C. (2011). Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. The Journal of Clinical Investigation 121, 1217-1221.
24. Nishikawa, S., Goldstein, R. A. & Nierras, C. R. (2008). The promise of human induced pluripotent stem cells for research and therapy. Nature Reviews Molecular Cell Biology 9, 725-729.
25. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K. & Daley, G. Q. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
26. Parker, S. C., Stitzel, M. L., Taylor, D. L., Orozco, J. M., Erdos, M. R., Akiyama, J. A., van Bueren, K. L., Chines, P. S., Narisu, N., NISC Comparative Sequencing Program, Black, B. L., Visel, A., Pennacchio, L. A., Collins, F. S., National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program Authors & NISC Comparative Sequencing Program Authors (2013). Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proceedings of the National Academy of Sciences of the United States of America 110, 17921-17926.
27. Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C. J., Rockowitz, S., Guo, X. Y., Zheng, D. Y. & Lachman, H. M. (2011). Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. Journal of Neurogenetics 25, 88-103.
28. Peng, R., Lin, G. & Li, J. (2015). Potential pitfalls of CRISPR/Cas9-mediated genome editing. The FEBS Journal doi: 10.1111/febs.13586 (Epub ahead of print).
29. Perez-Pinera, P., Ousterout, D. G., Brunger, J. M., Farin, A. M., Glass, K. A., Guilak, F., Crawford, G. E., Hartemink, A. J. & Gersbach, C. A. (2013). Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nature Methods 10, 239-242.
30. Phillips-Cremins, J. E., Sauria, M. E., Sanyal, A., Gerasimova, T. I., Lajoie, B. R., Bell, J. S., Ong, C. T., Hookway, T. A., Guo, C., Sun, Y., Bland, M. J., Wagstaff, W., Dalton, S., McDevitt, T. C., Sen, R., Dekker, J., Taylor, J. & Corces, V. G. (2013). Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153, 1281-1295.
31. Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P. & Lim, W. A. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173-1183.
32. Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X. B., Makarova, K. S., Koonin, E. V., Sharp, P. A. & Zhang, F. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186-191.
33. Raya, A., Rodriguez-Piza, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castella, M., Rio, P., Sleep, E., González, F., Tiscornia, G., Garreta, E., Aasen, T., Veiga, A., Verma, I. M., Surrallés, J., Bueren, J. & Izpisúa Belmonte, J. C. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59.
34. Rosner, M. H., Vigano, M. A., Ozato, K., Timmons, P. M., Poirier, F., Rigby, P. W. & Staudt, L. M. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345, 686-692.
35. Sarkar, A. & Hochedlinger, K. (2013). The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 12, 15-30.
36. Scholer, H. R., Ruppert, S., Suzuki, N., Chowdhury, K. & Gruss, P. (1990). New type of POU domain in germ line-specific protein Oct-4. Nature 344, 435-439.
37. Shin, J., Ming, G. L. & Song, H. (2014). Decoding neural transcriptomes and epigenomes via high-throughput sequencing. Nature Neuroscience 17, 1463-1475.
38. Song, C. X., Szulwach, K. E., Fu, Y., Dai, Q., Yi, C., Li, X., Li, Y., Chen, C. H., Zhang, W., Jian, X., Wang, J., Zhang, L., Looney, T. J., Zhang, B., Godley, L. A., Hicks, L. M., Lahn, B. T., Jin, P. & He, C. (2011). Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nature Biotechnology 29, 68-72.
39. Splinter, E., Heath, H., Kooren, J., Palstra, R. J., Klous, P., Grosveld, F., Galjart, N. & de Laat, W. (2006). CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes & Development 20, 2349-2354.
40. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L. & Rao, A. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935.
41. Takahashi, K. & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
42. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
43. Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S. & Vale, R. D. (2014). A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159, 635-646.
44. Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I. & Young, R. A. (2013). Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319.
45. Yang, H. J., Ratnapriya, R., Cogliati, T., Kim, J. W. & Swaroop, A. (2015). Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease. Progress in Retinal and Eye Research 46, 1-30.
46. Ye, L., Chang, J. C., Lin, C., Sun, X., Yu, J. & Kan, Y. W. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proceedings of the National Academy of Sciences of the United States of America 106, 9826-9830.
47. Yuan, H., Corbi, N., Basilico, C. & Dailey, L. (1995). Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes & Development 9, 2635-2645.
48. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., Mutalif, R. A., Navasankari, R., Zhang, Y., Tse, H. F., Stewart, C. L. & Colman, A. (2011). A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45.
49. Zhang, M. L., Li, K., Xie, M. & Ding, S. (2015). Chemical approaches to controlling cell fate. In: Principles of Developmental Genetics, 2nd Edition (ed. S. A. Moody), pp. 59-76. Amsterdam, the Netherlands: Elsevier.